Gas Liquid Chromatographic Determination of Acetaminophen in Blood Plasma

Abstract

An improved procedure for the GLC determination of acetaminophen (N-acetyl-p-aminophenol) in the presence of N-butyryl-p-aminophenol (internal standard) is described. The method is based on the extraction of acetaminophen from plasma with ethyl acetate containing a known amount of N-butyryl-p-aminophenol. Following a clean-up step with a basic buffer solution and neutralization with acid, both compounds are reextracted into ethyl acetate. The ethyl acetate is evaporated to dryness and the residue dissolved in 5 μl of pyridine and 15 μl of acetic anhydride at 42°C. One to 2 μl samples are injected directly into the gas chromatograph. This extraction process does not give rise to troublesome interfering peaks in the chromatogram. In addition, it prevents late-eluting peaks which inhibit efficient processing of samples. The recovery of acetaminophen is approximately 54%, and the limit of quantitation 0.5 μg/ml of plasma. Data are presented to illustrate the practicality of the method for bioavailability evaluation from acetaminophen plasma levels after oral administration of 325 mg of an acetaminophen dosage form.     

Determination of Bumetanide in Human Plasma and Urine by High-Performance Liquid Chromatography with Fluorescence Detection

Abstract

This paper describes a new high-pressure liquid chromatographic method used for quantitation of bumetanide in urine and plasma. Compared to previously reported methods, this assay offers the advantages of increased sensitivity, shortened sample preparation time and decreased instrumentation requirements. After addition of the 4-benzyl derivative of bumetanide as the internal standard, both urine and plasma underwent a single extraction with ethyl acetate at an acidic pH. The organic extract was separated, evaporated to dryness, reconstituted with methanol, and chromatographed using a reversed-phase C-18 radial compression cartridge with fluorescence detection. Sensitivity limits are approximately 1 ng of bumetanide per mL of plasma, with a coefficient of variation for identical samples never exceeding 6%. The method lends itself to pharmacokinetic and pharmacodynamic studies of bumetanide in humans following single therapeutic doses.     

分散固相萃取/高效液相色谱法测定水产品中氯苯胍的残留量

建立了水产品中氯苯胍残留的分散固相萃取/高效液相色谱检测法.采用酸化乙酸乙酯为提取溶剂、C18填料为基质分散剂提取水产品中残留的氯苯胍,经中性氧化铝柱净化,浓缩后用乙腈水溶液定容,经正己烷脱脂后上机检测,外标法定量.优化的色谱条件为:采用Agilent ODS-C18色谱柱(250 mm×4.6 mm,5μm)分离,以...     

固相萃取-气相色谱法测定茶叶中甲胺磷残留量

茶叶样品经乙酸乙酯提取,上清液于50℃蒸发至近干,加入乙酸乙酯溶解残渣后,经硅胶-石墨化碳混合柱净化。先以乙酸乙酯洗脱去除杂质,再以碱化乙腈洗脱并收集流出液,在50℃蒸发至近干,加乙酸乙酯定容至1mL,供气相色谱分析。采用DB-1701色谱柱分离和火焰光度检测器检测,所得甲胺磷的线性范围为0.010～1.00mg·L-1,方法的检出限(3S/N)为0.005mg·kg-1。在0.010,0.020,0.080 mg·kg-1 3个浓度水平下进行回收试验,甲胺磷的回收率在85.0%～90.9%之间,相对标准偏差(n=6)在2.2%～4.3%之间。     

Simultaneous determination of pantothenic acid and hopantenic acid in biological samples and natural products by gas chromatography-mass fragmentography

A method for the simultaneous determination of pantothenic acid and hopantenic acid in plasma samples was developed using gas chromatography-mass spectrometry with multiple ion detection. Plasma samples were directly purified without deproteinization on an ion-exchange resin, and the eluate was extracted with ethyl acetate under acidic conditions. The organic layer was evaporated to dryness under a stream of nitrogen, and the residue was dissolved in an internal standard solution. Pantothenic and hopantenic acids were converted into their trimethylsilyl derivatives by treating with bis(trimethylsilyl)trifluoroacetamide. Aliquots of this solution were injected into the gas chromatograph-mass spectrometer, which was equipped with a wide-bore fused-silica column (DB-17) and analysed by the multiple ion detection method. The detection limits for pantothenic acid and hopantenic acid in plasma were 1 ng/ml each at a signal-to-noise ratio of 5. This method was applied to a study of the assay of pantothenic acid and hopantenic acid in biological samples and natural products.     

Gas Liquid Chromatographic Determination of Caffeine in Breast Milk and Blood Plasma

Abstract

An improved procedure for the determination of caffeine in the presence of bupivicaine (internal standard) using gas liquid chromatography with nitrogen phosphorous detection is described. The method is based on the extraction of caffeine from plasma with a mixture of chloroform and isopropanol (95:5). The chloroform and isopropanol mixture is evaporated to dryness and the residue dissolved in 500 μl of ethyl acetate. One to 2 μl samples are injected directly into the gas chromatograph. This extraction process doesn't give rise to troublesome interfering peaks in the chromatogram. The recovery of caffeine from plasma and breast milk is approximately 99.7% and 94.1% respectively. The coefficient variation of the assay from plasma and breast milk is 2.90% and 1.18% respectively. The limit of quantitation is 0.05 mcg/ml of plasma or breast milk. Data are presented to illustrate the practicality of the method for bioavailability and pharmacokinetic evaluation of caffeine plasma and breast milk levels after oral administration of 100 mg of caffeine to lactating mothers.     

Detection and identification of zeranol in chicken or rabbit liver by liquid chromatography-electrospray tandem mass spectrometry

A sensitive, specific, and reliable liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed for detection and identification of zeranol in chicken or rabbit liver. A homogenized liver sample was hydrolyzed with beta-glucuronidase/arylsulfatase, and the hydrolysate was extracted with ethyl ether. The supernatant was evaporated to dryness, and the residue was dissolved in chloroform and re-extracted with sodium hydroxide. After acidification, the extract was cleaned up on a C18 solid-phase extraction cartridge and analyzed by electrospray LC-MS/MS in the negative ion mode. The multiple reaction monitoring transition from both m/z 321 to 277 and m/z 321 to 303 was monitored for confirmation, and the product ion of 277 was used for quantitation. Separation was performed on a Waters XTettra C18 column (50 x 2.1 mm, 3.5 microm) combined with a safeguard column (Symmetry C18, 20 x 3.9 mm, 5 microm), using a gradient elution with acetonitrile and 20 mM ammonium acetate. Calibration curves were prepared and good linearity was achieved over the concentration ranges tested. For all liver samples fortified at 3 different levels of 1, 5, and 50 microg/kg, the overall recoveries and relative standard deviations were in the range of 61-90 and 8-13%, respectively. The limit of quantitation based on the assay validation was 1 microg/kg. The method had been used on a routine basis for detection and identification of zeranol in liver samples.     

Semi-automated, solid-phase extraction procedure for liquid chromatographic determination of papaverine, diltiazem, desipramine and nicardipine in urine

Summary A solid-phase extraction (SPE) method for sample clean-up followed by a reversed-phase HPLC procedure is reported for the assay of papaverine, diltiazem, desipramine and nicardipine in urine. Disposable extraction cartridges (DECs) filled with C18, C8, C2, CH and PH silica-bonded phases were used. The effect on recovery of sample pH, composition of washing and elution solvents and nature of SPE cartridge were evaluated. The selectivity of SPE was examined using spiked urine samples and the PH cartridge gave rise to the cleanest extracts. Phenyl cartridges were conditioned with methanol and acetic acid-sodium acetate buffer. Urine sample was buffered and then applied to the DEC. The washing step was with acetone-water and subsequently with methanol-acetate buffer. The analytes were eluted with methanol-acetate buffer. The extract was evaporated to dryness, reconstituted in mobile phase, and chromatographed on a reversed-phase C18 column with UV detection at 212 nm. Recoveries of the tested compounds from spiked urine samples using the PH cartridge were in all cases>80%. The within-day and between-day repeatabilities were<5% and 9%, respectively.     

高效液相色谱快速测定水产品中孔雀石绿、结晶紫及其无色产物的残留量

采用高效液相色谱同时检测水产品中孔雀石绿、结晶紫及无色孔雀石绿和无色结晶紫的残留量,样品经提取、净化处理后所得残渣用乙腈溶解后,通过采用C_(18)色谱柱,以乙腈(A)和pH3.0的0.02 mol·L~(-1)磷酸二氢钾缓冲溶液(B)按不同比例混合进行梯度淋洗,实现孔雀石绿、结晶紫及其代谢物的分离。用自制的二氧化铅柱氧化无色孔雀石绿及无色结晶紫。在588 nm波长处,测定4种物质的质量浓度在0.3～6.0 mg·L~(-1)范围内与其峰面积呈线性关系,相对标准偏差(n=6)小于2.5%,检出限(3S/N)小于1.9μg·kg~(-1),分析时间20 min。以凤尾鱼罐头为基体进行回收试验,方法的回收率在71.5%～88.6%范围。     

超高效液相色谱法测定甘蔗和土壤中敌草隆残留

建立了一种测定甘蔗和土壤中敌草隆农药残留的超高效液相色谱(UPLC)方法.样品经水和甲醇提取,二氯甲烷液-液分配后,过中性氧化铝柱纯化,用石油醚:乙酸乙酯的混合液(体积比85:15)淋洗和洗脱,洗脱液经减压浓缩后用5 mL乙腈定容.采用UPLC分离,紫外检测器检测,外标法定量.敌草隆在0.02～5.0 mg/L范围线性...     

Development and validation of a GC-EI-MS method with reduced adsorption loss for the quantification of olanzapine in human plasma

A simple and sensitive GC-EI-MS method using solvent extraction and evaporation was developed for the determination of olanzapine concentrations in plasma samples. Because olanzapine and promazine, which was used as the internal standard (IS), are nitrogenous bases, they can adsorb to the weakly acidic silanol groups on the surfaces of glass centrifuge tubes during solvent extraction and evaporation. Silylation of the glass tubes, addition of triethylamine (TEA), and use of a sample solution with a basic pH could prevent adsorption loss. The extraction method involved mixing plasma (500 μL) in a silylated glass tube with a promazine solution (2 μg/mL, 25 μL) in methanol containing 1% TEA. After addition of aqueous sodium carbonate (0.5 mol/L, pH 11.1, 1 mL) and extraction into 3 mL of dichloromethane/n-hexane (1:1, v/v) containing 1% TEA, the organic phase was evaporated to dryness in a silylated glass tube. The residue was dissolved in ethyl acetate containing 1% TEA (50 μL). For GC-EI-MS analysis, the calibration curves of olanzapine in human plasma were linear from 0.5 to 100 ng/mL. Intra- and interday precisions in plasma were both less than 7.36% (coefficient of variation), and the accuracy was between 94.6 and 110% for solutions with concentrations greater than 0.5 ng/mL. The limit of quantification was 0.5 ng/mL in plasma. The assay was applied to therapeutic drug monitoring in samples from three schizophrenic patients.     

Quantitation of Cyproheptadine in Plasma and Urine by HPLC

Abstract

A sensitive, reliable and specific high performance liquid chromatographic procedure has been developed for the quantitation of cyproheptadine in plasma or urine. After extraction of the drug with ethyl acetate from alkalinized samples, the organic extract was evaporated to dryness, reconstituted with acetonitrile and chromatographed using a C₈ reversed-phase analytical column with UV detection at 254 nm. The average recoveries of cyproheptadine from spiked plasma and urine samples in the concentrations ranging from 0.2 – 3 mcg/ml were 95.7 and 100.3%, respectively and their respective CV was 4.1 and 3.9%. Regression analyses for the calibration plots for plasma and urine standards obtained on three different days for the drug concentrations between 0.2 – 3 mcg/ml indicated excellent linearity (r > 0.999) and reproducibility (CV < 2.0%, p > 0.01). The limit of sensitivity was 50 ng/ml for both plasma and urine samples. The method was applied to monitor the plasma concentration versus time profile of cyproheptadine following a single bolus IV dose of 1 mg/kg in a dog.

Urine samples taken from a human subject for the duration of 24 hours following a single oral dose of 8 mg showed that the cumulative amount excreted in urine as cyproheptadine was approximately 1% of the dose.     

High Performance Liquid Chromatographic Determination of (-)-N-Formylnorephedrine in Plasma

Abstract

An HPLC procedure for the detection and quantitative estimation of (-)-N-formylnorephedrine in rabbit plasma had been developed. The procedure involved the extraction of (-)-N-formylnorephedrine from plasma spiked with the internal standard (phenacetin), using ethyl acetate. The ethyl acetate extract is evaporated under nitrogen and the residue is reconstituted in water and injected onto the column. A u-Bondapak-C18 column 30 cm × 3.9 mm ID was used. The mobile phase is 20% acetonitrile in water; at a flow rate of 1.5 ml/min and uv detection at 256 nm. A linear relationship between concentration and peak height ratio (I/internal standard) was obtained (r = 1.00). The reported procedure allows the measurement of (-)-formylnorephedrine in concentrations as low as 150 ng/ml of plasma with total procedure time of about 10 min. The applicability of the procedure to pharmacokinetic studies is illustrated and metabolites are shown not to interfere with the assay procedure.     

GLC and HPLC Determination of Diazepam and its Degradation Products in Pharmaceutical formulations

Abstract

Stability-indicating high performance liquid chromatographic (HPLC) and gas-liquid chromatographic (GLC) assays for diazepam in pharmaceutical formulations are described. In HPLC method, the material is extracted with 5 % aqueous methanol and chromatographed on a dimethyloctyl stationary phase using methanol-water-acetic acid (80: 20: 1) and propyl paraben internal standard. The system separated diazepam from the main degradation products, desmethyl diazepam (a synthetic precursor of diazepam) and the excipients present in ampoules and syrups. The GLC method included the extraction of diazepam and 2-methylamino-5-chiorobenzo-phenone (MACB) from aqueous acidic solution into chloro form leaving the other degradation products in the aqueous phase. The chloroform extract is evaporated to dryness, dissolved in chloroform containing diethylhexyl phtha-late as internal standard and chromatographed on an OV-17 stationary phase using flame ionisation detector. The results are compared with the BP method described for each formulation.     

Simultaneous HPLC Determination of Oxcarbazepine,Carbamazepine and Their Metabolites in Serum

Abstract

We propose a simple procedure for the simultaneous determination of the anticonvulsants oxcarbazepine, carbamazepine and three of their metabolites (10-hydroxy-10, 11-dihydro-carbamazepine, trans-10, 11-dihydroxy-10, 11-dihydro-carbamazepine and 10, 11-epoxy-carbamazepine) in serum or plasma. The alkalinized sample is extracted with ethyl acetate. The extract is evaporated to dryness and taken up with the mobile phase. An aliquot is injected into the liquid chromatograph and eluted with water/methanol/acetonitrile (55/40/5, by vol.) on a 5-μm C-18 reversed-phase column. Eluent is monitored at 254 nm. No interference by other anticonvulsants or by endogenous constituents from the sample is observed. Owing to its good precision, specificity, sensitivity, and selectivity, this method is well adapted to the therapeutic monitoring of oxcarbazepine or carbamazepine treated patients, as well as for pharmacokinetic studies.     

Simultaneous Determination of Aromatic Isocyanates and Some Carcinogenic Amines in the Work Atmosphere by Reversed-Phase High-Performance Liquid Chromatography

Abstract

A reversed-phase high-performance liquid chromatographic method with UV-detection is described for the simultaneous determination of aromatic isocyanates and some carcinogenic aromatic amines which may be present together in the work atmosphere of the polyurethane industry. The air is sampled through ethanol which is made alkaline by potassium hydroxide (KOH). The isocyanates react instantaneously to the corresponding ethyl urethanes, while the amines remain in nonionized state. KOH, which has been added to catalyze the ethyl urethane reaction and eliminate the side reactions, is precipitated out with hydrochloric acid and the sample solution is evaporated to dryness. The residue is dissolved in 1 ml ethanol and water (1:1). A 50-ul aliquot of the resulting solution is chromatographed on a Rad Pak C₁₈ column and eluted isocratically with a mixture of tetrahydrofuran, acetonitrile and water buffered with acetate to some exact value in the pH range 5.5–7.0. The use of this pH range is favored both by the retention behaviour and UV-detectability of the aromatic amines.     

固相萃取和气相-质谱法测定主流烟气中苯并[a]芘的研究

 提出了一种用于测定主流烟气中痕量苯并 [a]芘的方法。以甲醇 正庚烷萃取体系初步处理主流烟气中的总粒相物 (TPM) ,接着以KOH甲醇溶液数毫升洗涤正庚烷萃取液 ,再将正庚烷萃取液适当浓缩后经过酸化的硅胶固相萃取小柱 ,流出液用N2 吹干后以乙酸乙酯 2 0 0 μL定容 ,对苯并 [a]芘进行选择离子监测方式下的气相 质谱法定量测定。方法的分离效果及重现性好 ,可用于复杂体系中痕量组分苯并 [a]芘的定量测定。     

磁固相萃取-高效液相色谱联用测定尿样中的1-羟基芘

采用磁固相萃取-高效液相色谱-荧光检测方法(MSPE-HPLC-FD)分析了尿样中芘代谢物1-羟基芘(1-Hydroxyperene 1-OHP).2mL尿样以0.1 mol/L醋酸钠溶液(pH 4.5)稀释至4 mL,酶水解后,再以0.1 mol/L醋酸钠溶液(pH 5.0)稀释至10mL,采用十八烷基膦酸改性的磁性介孔纳米粒子(50 mg)为萃取介质,对其进行MSPE富集,涡旋萃取1 min,甲醇解吸3min.解吸液经氮气吹干重新定容后,进行液相色谱分析.本方法在0.01～ 1.00 μg/L范围内线性良好(R2=0.9996);检出限为0.001μg/L日内相对标准偏差小于9.7％(n=5),日间相对标准偏差小于12.9％.将本方法应用于多个人体尿液样品中1-OHP含量的检测,结果满意.为确保结果的科学性和可靠性,测定结果用尿肌酐含量进行了归一化.     

A Simple and Rapid Reversed Phase High Performance Liquid Chromatographic Method for Quantification of Alprazolam and α-Hydroxyalprazolam in Plasma

Abstract

A simple and rapid reversed-phase liquid chromatographic method for the determination of alprazolam and a-hydroxyalprazolam in plasma is described. Flunictrazepam was used as internal standard. Plasma samples were buffered with sodium borate and extracted with dichloromethane /n-pentane 4:6 v/v for 60 sec on a vortex apparatus. Extraction solvent was evaporated to dryness and extraction residues were reconstituted in the mobile phase. Samples were chromatographed on a 5μ Lichrospher RP-18 column (25cm × 4mm i. d) using acetonitrile/water 40:60 v/v as the mobile phase. The column effluent was monitored at 230nm. The lower limit of detection was 1ng/ml for alprazolam and a-hydroxyalprazolam while the lower limit of quantification was 2ng/ml for both compounds. Peak height and plasma     

气相色谱法测定食品中己二酸

建立了气相色谱/氢火焰离子化检测器同时测定6种食品中己二酸含量的方法.该方法通过加酸助溶,采用乙酸乙酯提取食品样品中的己二酸,浓缩后再用硅烷化试剂进行衍生化处理.考察了温度、时间及衍生化试剂用量对己二酸硅烷化衍生效果的影响.以庚二酸内标法定量测定,定量限为5 mg/kg,在5～600 μg/mL范围内呈良好线性关系,相...